Track topics on Twitter Track topics that are important to you
Scott McMillan is joining uniQure (NASDAQ: QURE) as chief operating officer. Before coming to uniQure, a gene therapy developer split between The Netherlands and Lexington, MA, McMillan was senior vice president of quality and technical operations at AMAG Pharmaceuticals (NASDAQ: AMAG) in Waltham, MA. McMillan will be based at uniQure’s Lexington site. In other moves, […]
Original Article: UniQure Names McMillan COO, van Deventer Succeeds Retiring CSONEXT ARTICLE
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...